<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1124356</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>SHANK3 in vagal sensory neurons regulates body temperature, systemic inflammation, and sepsis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Linlin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1563565"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bang</surname>
<given-names>Sangsu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2171616"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Qianru</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/663355"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsuda</surname>
<given-names>Megumi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1057983"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/722863"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Yong-Hui</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ji</surname>
<given-names>Ru-Rong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref> <uri xlink:href="https://loop.frontiersin.org/people/467724"/>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Center for Translational Pain Medicine, Department of Anesthesiology, Duke University Medical Center</institution>, <addr-line>Durham, NC</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Genetics, Pediatrics and Neuroscience, Yale University School of Medicine</institution>, <addr-line>New Haven, CT</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Neurobiology, Duke University Medical Center</institution>, <addr-line>Durham, NC</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Cell Biology, Duke University Medical Center</institution>, <addr-line>Durham, NC</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ping-Heng Tan, Chi Mei Medical Center, Taiwan</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Haitham Amal, Hebrew University of Jerusalem, Israel; Luye Qin, University of South Dakota, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Ru-Rong Ji, <email xlink:href="mailto:ru-rong.ji@duke.edu">ru-rong.ji@duke.edu</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn004">
<p>&#x2020;ORCID: Ru-Rong Ji, <uri xlink:href="https://orcid.org/0000-0002-9355-3688">https://orcid.org/0000-0002-9355-3688</uri>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1124356</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Zhang, Bang, He, Matsuda, Luo, Jiang and Ji</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Zhang, Bang, He, Matsuda, Luo, Jiang and Ji</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Excessive inflammation has been implicated in autism spectrum disorder (ASD), but the underlying mechanisms have not been fully studied. SHANK3 is a synaptic scaffolding protein and mutations of <italic>SHANK3</italic> are involved in ASD. Shank3 expression in dorsal root ganglion sensory neurons also regulates heat pain and touch. However, the role of Shank3 in the vagus system remains unknown. We induced systemic inflammation by lipopolysaccharide (LPS) and measured body temperature and serum IL-6 levels in mice. We found that homozygous and heterozygous <italic>Shank3</italic> deficiency, but not <italic>Shank2</italic> and <italic>Trpv1</italic> deficiency, aggravates hypothermia, systemic inflammation (serum IL-6 levels), and sepsis mortality in mice, induced by lipopolysaccharide (LPS). Furthermore, these deficits can be recapitulated by specific deletion of <italic>Shank3</italic> in Nav1.8-expressing sensory neurons in conditional knockout (CKO) mice or by selective knockdown of <italic>Shank3</italic> or <italic>Trpm2</italic> in vagal sensory neurons in nodose ganglion (NG). Mice with <italic>Shank3</italic> deficiency have normal basal core temperature but fail to adjust body temperature after perturbations with lower or higher body temperatures or auricular vagus nerve stimulation. <italic>In situ</italic> hybridization with RNAscope revealed that <italic>Shank3</italic> is broadly expressed by vagal sensory neurons and this expression was largely lost in <italic>Shank3</italic> cKO mice. Mechanistically, <italic>Shank3</italic> regulates the expression of <italic>Trpm2</italic> in NG, as <italic>Trpm2</italic> but not <italic>Trpv1</italic> mRNA levels in NG were significantly reduced in <italic>Shank3</italic> KO mice. Our findings demonstrated a novel molecular mechanism by which Shank3 in vagal sensory neurons regulates body temperature, inflammation, and sepsis. We also provided new insights into inflammation dysregulation in ASD.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>nodose ganglion</kwd>
<kwd>sepsis</kwd>
<kwd>TRPM2</kwd>
<kwd>TRPV1</kwd>
<kwd>vagus nerve</kwd>
<kwd>pain</kwd>
<kwd>inflammation</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="47"/>
<page-count count="14"/>
<word-count count="7464"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Autism spectrum disorder (ASD) is defined by persistent deficits in the ability to initiate and to sustain reciprocal social interaction and social communication and characterized by a range of restricted, repetitive, and inflexible patterns of behavior, as well as various sensory abnormalities (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>). SHANK3 is a scaffolding protein located at excitatory synapses, and mutations of <italic>SHANK3</italic> (haploinsufficiency) may account for 1-2% of all ASD cases including Phelan-McDermid syndrome (PMS) (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). The disrupted striatum centered brain structures and synaptic transmission in this brain region are associated with ASD children with <italic>SHANK3</italic> mutations and animal models of <italic>Shank3</italic> deficiency (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Accumulating evidence has indicated the link between ASD and generalized immune dysfunction (hyper-inflammation). For example, proinflammatory cytokines (e.g., TNF-&#x3b1;, IL-6, IL-8) are increased in the brains of ASD individuals (<xref ref-type="bibr" rid="B10">10</xref>). Peripheral blood mononuclear cells from ASD patients produced more TNF-&#x3b1;, IL-1&#x3b2;, and IL-6 than control cells (<xref ref-type="bibr" rid="B11">11</xref>). The plasma and serum concentrations of IL-1&#x3b2;, IL-6, and IL-8 are also elevated in ASD samples compared with the healthy control samples (<xref ref-type="bibr" rid="B12">12</xref>). Upregulations of IL&#x2010;6 and IL&#x2010;17 levels were reported in pregnant rodent mothers upon maternal immune activation and IL&#x2010;6 may induce the secretion of IL&#x2010;17 (<xref ref-type="bibr" rid="B3">3</xref>). IL-6 and IL-17 were shown to promote autistic behaviors in animal models (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>). By contrast, anti-IL-6 or anti-IL-17 treatments can alleviate the autistic behaviors induced by maternal immune activation (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Frequent respiratory infections were found in 57% of ASD patients and regarded as an ASD comorbidity (<xref ref-type="bibr" rid="B4">4</xref>). Anti-biotic treatment may improve ASD-related behaviors (<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>). Subacute neuropsychiatric syndrome in girls with <italic>SHANK3</italic> mutations responds to immunomodulation (<xref ref-type="bibr" rid="B19">19</xref>). Preclinical study shows that acute inflammatory challenge induced by lipopolysaccharide (LPS) can unmask behavioral deficits of <italic>Shank3</italic>
<sup>+/&#x2212;</sup> mice (<xref ref-type="bibr" rid="B7">7</xref>). However, the mechanisms of excessive immune reaction in ASD are not fully understood.</p>
<p>Emerging roles for the gut microbiome and gut-brain axis have been implicated in ASD (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Notably, the vagus system plays a critical role in regulating the gut-brain axis (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Precision microbial-based therapy was shown to rescue social deficits in mouse models of ASD and, interestingly this rescue in <italic>Shank3B</italic> knockout mice depends upon the function of the vagus nerve (<xref ref-type="bibr" rid="B20">20</xref>). The molecular mechanisms underlying the vagus nerve modulation of ASD remain largely unknown. Recent studies have shown SHANK3 expression in the peripheral nervous system, such as primary sensory neurons of dorsal root ganglion (DRG); and furthermore, SHANK3 interacts with transient receptor potential ion channel V1 (TRPV1) and GABA<sub>A</sub> receptor in DRG neurons to regulate pain (<xref ref-type="bibr" rid="B24">24</xref>) and touch (<xref ref-type="bibr" rid="B25">25</xref>). Here we show that <italic>Shank3</italic> is also expressed by vagal sensory neurons and <italic>Shank3</italic> in nodose ganglion (NG) sensory neurons plays a crucial role in maintaining body temperature and protecting against systemic inflammation in responses to LPS challenge and temperature perturbations. Mechanistically, SHANK3 regulates the expression of TRPM2 (transient receptor potential melastatin 2), a nonselective Ca<sup>2+</sup> permeable cation channel in NG vagal sensory neurons.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Regents</title>
<p>AAV.CMV.HI. eGFP-Cre.WPRE.SV40 was from Addgene (Plasmid #105545). Shank3 siRNA (Cat# AM16708, ID:194441), Trpv1 siRNA (# AM16708, ID: 223137), and Trpm2 siRNA (# 1320001, ID: mss219854) were purchased from Thermo scientific. Control siRNA was purchased from Santa cruz biotech (#sc-37007), and RVG peptide (# AS-62566) was from Anaspec (Fremont, CA). Menthol (# W266507), capsaicin (# M2028), and LPS (# L2630) were purchased from Sigma.</p>
</sec>
<sec id="s2_2">
<title>Animals</title>
<p>
<italic>Shank3</italic> knockout mice (exons 4 to 22 deletion, &#x394;4&#x2013;22, C57BL/6 background RRID: MGI:5800311) (<xref ref-type="bibr" rid="B8">8</xref>), Shank3 flox/flox mice (RRID: MGI: 5800310) (<xref ref-type="bibr" rid="B26">26</xref>), and Shank2 flox/flox mice were generated at Yong-Hui Jiang&#x2019;s laboratory at Duke University Medical Center. Both Shank2 and Shank3 floxed mice were backcrossed to C57BL/6J for more than 10 generations. To generate sensory neuron-specific deletion of Shank3 and Shank2, the flox mice were crossed with Nav1.8-cre mice, provided by Dr. Rohini Kuner of University of Heidelberg (<xref ref-type="bibr" rid="B27">27</xref>). Adult mice (males and females, 8&#x2013;10 weeks) were used for behavioral and biochemical studies. CD1 mice (males and females, 8&#x2013;10 weeks, Charles River Laboratories) were used for some siRNA knockdown experiments. All the mouse procedures were approved by the Institutional Animal Care &amp; Use Committee of Duke University. Two to five mice were housed in each cage under a 12-hour alternating light-dark cycle with ad libitum access to water and food. Sample sizes were estimated based on our previous studies for similar types of behavioral and biochemical analyses (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B28">28</xref>).</p>
</sec>
<sec id="s2_3">
<title>Peri-neural injection of virus or siRNA in the vagus nerve</title>
<p>The siRNA preparation and injection were conducted as we previously described (<xref ref-type="bibr" rid="B29">29</xref>). For siRNA delivery to the vagus nerve, we mixed 100 nM siRNA with 1 &#xb5;M RVG peptide that can facilitate siRNA uptake by neurons (<xref ref-type="bibr" rid="B30">30</xref>). For AAV9 virus delivery to vagus nerve, we mixed 1 x 10<sup>9</sup> virus in 10 &#xb5;l of PBS. The vagal nerve was exposed as previously described (<xref ref-type="bibr" rid="B31">31</xref>). Mice were anesthetized with isoflurane and a midline cervical muscle and salivary glands were exposed by blunt dissection until the trachea was visible. The vagus nerve was gently separated from the artery, and bilateral peri-neural injections were conducted to deliver siRNA or virus (5 &#x3bc;l) using a glass electrode with tip size of 1 &#xb5;m. The knockdown effects of siRNA and AAV9 virus were validated by examining the expression of <italic>Shank3</italic>, <italic>Trpm2</italic>, and <italic>Trpv1</italic> in vagal sensory neurons in nodose ganglion (NG) using <italic>in situ</italic> hybridization.</p>
</sec>
<sec id="s2_4">
<title>Vagal nerve stimulation</title>
<p>The 5% menthol and 100 &#xb5;M capsaicin were painted into left ear auricular acupoint or skin (50 &#xb5;l) to measure the body temperature change. Mice were lightly anesthetized with 2.5% isoflurane and then painted by fine brush.</p>
</sec>
<sec id="s2_5">
<title>LPS model of systemic inflammation and rectal temperature measurement</title>
<p>The systemic inflammation was generated by intraperitoneal injection of 1 mg/kg LPS (from Escherichia coli O111:B4) prepared in PBS (100 mg/ml stock). Body temperature measured before LPS injection, then at 0.5, 1, 3, 6, 24, 48, 72, and 96 hours after the LPS injection. The environmental temperature was maintained at 23 &#xb1; 0.5&#xb0;C. To obtain a rectal temperature, the mouse is hand-restrained (briefly anesthetized) and placed on a horizontal surface (cage lid) with the tail lifted, and a probe (covered with Vaseline) was gently inserted into the rectum to a fixed depth of 2&#xa0;cm. The rectal temperature was measured by the TA-29 flexible implantable probe and TC-344C temperature measuring unit (Warner Instruments., Hamden, CT, USA).</p>
</sec>
<sec id="s2_6">
<title>Electrocardiogram recordings</title>
<p>For ECG recording, the silver wires were implanted in the left abdomen below the heart and the right upper shoulder. Two electrodes were fixed to the incised tissues in mice using a 26 G needle under isoflurane anesthesia (<xref ref-type="bibr" rid="B32">32</xref>). The silver wires were exposed outside the neck region and put on the small jacket for the prevention of biting. The silver wires were exposed outside the neck region for the prevention of biting. After exposure to the menthol into ear acupoint region (concha area in outer ear), the ECG activity was measured in awake mice. The shaking induced electrical noise was excluded during data analysis. The analog electrical signal was amplified by a microelectrode ac amplifier (AM systems, model 1800) and converted by Digidata 1440A (Molecular device). Signals were filtered at 2 kHz and digitized at 5 kHz. Data were stored and analyzed with a personal computer using pCLAMP 10 (Molecular Devices) software.</p>
</sec>
<sec id="s2_7">
<title>RNAscope <italic>in situ</italic> hybridization</title>
<p>Mice were briefly anesthetized with 4% isoflurane and transcardially with PBS and 4% paraformaldehyde. Following perfusion, nodose ganglia (NG) were collected and postfixed in the same fixative overnight at 4&#xb0;C. NG tissues were embedded in OCT medium (Tissue-Tek), sectioned (14 &#x3bc;m) in a cryostat, and thaw-mounted onto Superfrost Plus slides (VWR). <italic>In situ</italic> hybridization was performed using the RNAscope system (Advanced Cell Diagnostics) following the manufacturer&#x2019;s instructions. The RNA scope probes for mouse <italic>Shank3</italic> (# 417371), <italic>Trpm2</italic> (# 316831-C3), and <italic>Trpv1</italic> (# 313331-C3) were designed by Advanced Cell Diagnostics and the RNAscope multiplex fluorescent assays were performed according to the manufacturer&#x2019;s instructions. Pre-hybridization and hybridization, and then washing were performed according to standard methods. All images were acquired with the same settings using a confocal microscope under 20x magnification. For quantification, four non-adjacent NG sections from each animal and four animals per group were included. The intensity score (0: no signal, 1: weak signal; 2: medium signal, and 3: strong signal) was used to semi-quantify the mRNA signals blindly. We also quantified the number of mRNA-labeled punctate dots (puncta) in each neuron using Image J.</p>
</sec>
<sec id="s2_8">
<title>RT-qPCR</title>
<p>Total RNAs from nodose ganglia were extracted using the Direct-zol&#x2122; RNA MiniPrep Kit (Zymo Research), and 0.5-1 &#x3bc;g of RNA was reverse-transcribed using the iScript cDNA Synthesis<sup>&#xae;</sup> (Bio-Rad). Specific primers, including <italic>Gapdh</italic> control, were designed using IDT SciTools Real-Time PCR software. We performed gene-specific mRNA analyses using the CFX96 Real-Time PCR system (BioRad). Quantitative PCR amplification reactions contained the same amount of Reverse transcription (RT) product, including 10 &#x3bc;l of 2&#xd7; iQSYBR-green mix (BioRad) and 100-300 nM of forward and reverse primers in a final volume of 15 &#x3bc;l. Primer efficiency was obtained from the standard curve and integrated for calculation of the relative gene expression, which was based on real-time PCR threshold values of different transcripts and groups.</p>
<p>
<italic>Trpm2</italic> forward: TGCCTCACCTGCTCTTTGCC</p>
<p>
<italic>Trpm2</italic> reverse: TCTGTGTGTTCCTGCACCTA</p>
<p>
<italic>TRPV1</italic> forward: ATGTTCGTCTACCTCGTGTTCTTG</p>
<p>
<italic>TRPV1</italic> reverse: AGGCAGTGAGTTATTCTTCCCATCC</p>
<p>
<italic>TRPM8</italic> forward GTTGGACCTTGCCAGTGATGAG</p>
<p>
<italic>TRPM8</italic> reverse CCATTCTCCAGAAAGAGGCGGA</p>
<p>
<italic>SCN10A</italic> forward ATGGAGGTCAGCCAGGACTACA</p>
<p>
<italic>SCN10A</italic> reverse CTGTGAGGTTGTCCGCACTGAA</p>
<p>
<italic>Gapdh</italic> forward: AGGTCGGTGTGAACGGATTTG</p>
<p>
<italic>Gapdh</italic> reverse: GGGGTCGTTGATGGCAACA</p>
</sec>
<sec id="s2_9">
<title>ELISA</title>
<p>To detect serum cytokine levels, we purchased mouse ELISA kits from R&amp;D system (Minneapolis, MN, Cat# DY406 for IL-6). We collected  whole blood from a facial vein (30 &#x3bc;l~60 &#x3bc;l). The collected blood was allowed to clot for 30 minutes at room temperature. The clot was then removed in a refrigerated centrifuge at 2,000 x g for 10&#xa0;min to collect the supernatant (serum). To perform each ELISA assay, we used 5 &#x3bc;l of serum. We measured the absorbance of OD450 using a microplate reader (Bio-Rad) and then quantified the data by MPM6 software (BioRad).</p>
</sec>
<sec id="s2_10">
<title>Statistical analysis</title>
<p>All the data in the figures were expressed as mean &#xb1; SEM. We analyzed the biochemical or survival data using Prism GraphPad 6.0. One-Way ANOVA with Bonferroni <italic>post hoc</italic> or Two-Way ANOVA with Tukey&#x2019;s posthoc test or unpaired t-test were used to assess biochemical, temperature, and ECG data. We analyzed the survival ratio using a Kaplan&#x2013;Meier method and log-rank (Mantel-Cox) test. If the overall log-rank test was statistically significant (<italic>p</italic> &lt; 0.05), we further performed pairwise comparisons of two groups. <italic>p</italic> &lt; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>LPS-induced hypothermia, systemic inflammation and mortality are aggravated in <italic>Shank3</italic> global knockout mice</title>
<p>To investigate an overall role of <italic>Shank3</italic> in LPS-induced hypothermia, inflammation, and mortality, we employed <italic>Shank3</italic> &#x25b3;e4-22 mutant mice, in which exons 4 to 22 were deleted and SHANK3 protein is completely lost (<xref ref-type="bibr" rid="B8">8</xref>). In the current study, we referred to &#x25b3;e4-22 mutant mice as <italic>Shank3</italic> global knockout mice (GKO). First, we compared the baseline body temperature in wild-type (WT) and heterozygous (<italic>Shank3<sup>+/-</sup>
</italic>) and homozygous (<italic>Shank3<sup>-/-</sup>
</italic>) GKO mice. The rectal temperature analysis revealed that <italic>Shank3<sup>-/-</sup>
</italic> mice exhibited no change in body core temperature as compared to WT and <italic>Shank3<sup>+/-</sup>
</italic> mice (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>), suggesting that SHANK3 is not involved in the regulation of basal body temperature. Then, we challenged these mice with intraperitoneal (i.p.) injection of LPS (1 mg/kg) to induce sepsis (<xref ref-type="bibr" rid="B28">28</xref>). Herein, we found a rapid and transient hyperthermia in WT mice, as indicated by an elevation in rectal temperature at 30 minutes after LPS injection as compared to baseline (<italic>p</italic> = 0.0158, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). Interestingly, this hyperthermia was completely compromised in both <italic>Shank3<sup>+/-</sup>
</italic> and <italic>Shank3<sup>-/-</sup>
</italic> mice (<italic>p</italic> = 0.0106 and <italic>p</italic> = 0.0004, respectively) when compared with WT mice (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). We also revealed that LPS-induced hypothermia started at 3 hours (<italic>p</italic> = 0.0008), peaked at 6 hours (<italic>p</italic> &lt; 0.0001), and continued for 24 hours (p=0.0488) after LPS intervention in WT mice. Furthermore, as compared to WT mice, this hypothermia was observed within 1 hour (<italic>p</italic> = 0.0411) and lasted for at least 48 hours (p &lt; 0.0001) after LPS exposure in <italic>Shank3<sup>-/-</sup>
</italic> mice. More strikingly, sepsis-induced hypothermia was significantly aggravated in both <italic>Shank3<sup>+/-</sup>
</italic> and <italic>Shank3<sup>-/-</sup>
</italic> mice (F (2, 408) = 48.24, <italic>p</italic> &lt; 0.0001, two-way ANOVA, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). There was also significant difference between heterozygous and homozygous mice (F (1, 245) = 11.35, <italic>p</italic> = 0.0011, two-way ANOVA, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). This result suggested that loss of one copy of <italic>Shank3</italic> is sufficient to cause hyperthermia defects and hypothermia exacerbation, which is reminiscent of autism patients with haploinsufficiency of <italic>SHANK3</italic>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>
<italic>Shank3</italic> global mutants exhibit exacerbation in LPS-induced hypothermia, systemic inflammation and mortality in C57BL/6 mice. <bold>(A)</bold> Time course of rectal temperature after LPS injection in Wild-type (WT, <italic>Shank3</italic>
<sup>+/+</sup>) mice, heterozygous (<italic>Shank3</italic>
<sup>+/&#x2212;</sup>) mice and homozygous (<italic>Shank3</italic>
<sup>&#x2212;/&#x2212;</sup>) mice. <bold>(B)</bold> Serum IL-6 levels, revealed by ELISA, in WT and <italic>Shank3</italic>
<sup>&#x2212;/&#x2212;</sup> mice at different times with LPS. <bold>(C)</bold> Survival curves of WT, <italic>Shank3</italic>
<sup>+/&#x2212;</sup> and <italic>Shank3</italic>
<sup>&#x2212;/&#x2212;</sup> mice treated with LPS. LPS (1mg/kg) was injected <italic>via</italic> intraperitoneal (i.p.) route. Data are expressed as mean &#xb1; SEM and analyzed by two-way ANOVA with Bonferroni <italic>post hoc</italic> test <bold>(A, B)</bold> and Mantel-Cox test <bold>(C)</bold>. <sup>#</sup>
<italic>p &lt;</italic>0.05, <sup>###</sup>
<italic>p &lt;</italic>0.001, <sup>####</sup>
<italic>p &lt;</italic>0.0001 versus baseline. <sup>*</sup>
<italic>p &lt;</italic>0.05, <sup>**</sup>
<italic>p &lt;</italic>0.01, <sup>***</sup>
<italic>p &lt;</italic>0.001, <sup>****</sup>
<italic>p &lt;</italic>0.0001 versus WT mice. Sample sizes are indicated in brackets. n.s., not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1124356-g001.tif"/>
</fig>
<p>Next, we investigated whether sepsis-induced systemic inflammation was altered in <italic>Shank3</italic> mutant mice. Pro-inflammatory cytokine IL-6 is well recognized as a biomarker for sepsis and sepsis-associated death (<xref ref-type="bibr" rid="B28">28</xref>). We detected robust increases of serum IL-6 levels at 6 hours after LPS injection in <italic>Shank3<sup>-/-</sup>
</italic> mice as compared to WT mice (F (1, 24) = 0.1450, <italic>p</italic> = 0.008226, two-way ANOVA, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>).</p>
<p>Also, we evaluated survival rate following LPS injection among three genotypes. Low-dose LPS at 1 mg/kg resulted in a very low mortality (10%, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>) in WT mice. As compared to WT mice, we found a slight increase (23.33%) in mortality in LPS-treated <italic>Shank3<sup>+/-</sup>
</italic> mice (<italic>p</italic> = 0.1062, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>) but a significant increase (37.37%) in mortality in LPS-treated <italic>Shank3<sup>-/-</sup>
</italic> mice (<italic>p</italic> = 0.0152, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). Collectively, these data indicate that SHANK3 confers protection against hypothermia, systemic inflammation and septic death following LPS injection.</p>
</sec>
<sec id="s3_2">
<title>
<italic>Shank3</italic> deletion in vagal sensory neurons exacerbates LPS-induced hypothermia, systemic inflammation, and mortality</title>
<p>Vagus nerve stimulation has been shown to protect against sepsis and systemic inflammation (<xref ref-type="bibr" rid="B22">22</xref>). Recent studies reported <italic>Shank3</italic> expression in peripheral sensory neurons of DRG (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). However, the expression and role of SHANK3 in the vagus system is unclear. Using a sensitive RNA scope assay, we found extensive <italic>Shank3</italic> mRNA expression in majority of vagal sensory neurons in nodose ganglia (NG, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). To evaluate an underlying contribution of peripheral SHANK3 to hypothermia regulation, we generated <italic>Shank3</italic> conditional knockout mice by crossing <italic>Shank3</italic>-floxed mice with <italic>Nav1.8</italic>-<italic>Cre</italic> mice, leading to specific deletion of <italic>Shank3</italic> in <italic>Nav1.8-</italic>expressing peripheral sensory neurons including NG neurons (<xref ref-type="bibr" rid="B33">33</xref>). In this study, we referred to <italic>Shank3<sup>f/f</sup>
</italic> mice as littermate control wildtype (WT) mice, and referred to <italic>Nav1.8-cre; Shank3<sup>f/+</sup>
</italic> and <italic>Nav1.8-cre; Shank3<sup>f/f</sup>
</italic> mice as <italic>Shank3</italic> conditional knockout (CKO) heterozygous and homozygous mice. Notably, <italic>Shank3</italic> expression was substantially reduced in CKO mice (<italic>Nav1.8-cre; Shank3<sup>f/f</sup>
</italic> mice) as compared to <italic>Shank3<sup>f/f</sup>
</italic> mice (<italic>p</italic> = 0.0017, <xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). This result indicates a selective expression of <italic>Shank3</italic> in NG sensory neurons and also validated <italic>Shank3</italic> CKO mice.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>LPS-induced hypothermia, systemic inflammation and mortality are aggravated in <italic>Shank3</italic> CKO C57BL/6 mice. <italic>Shank3</italic> CKO mice were generated by crossing <italic>Shank3</italic>-floxed mice with <italic>Nav1.8</italic>-<italic>Cre</italic> mice, leading to specific loss of <italic>Shank3</italic> in Nav1.8-expressing sensory neurons. <bold>(A)</bold> <italic>In situ</italic> hybridization (ISH) images showing <italic>Shank3</italic> mRNA (red) expression in vagal sensory neurons in nodose ganglia (NG) of <italic>Shank3</italic>
<sup>f/f</sup> mice and <italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/f</sup> mice. Scale bar, 50 &#x3bc;m. <bold>(B)</bold> Quantification of the number of <italic>Shank3</italic> puncta in NG neurons. <bold>(C)</bold> Time course of rectal temperature after LPS (1mg/kg, i.p.) injection in <italic>Shank3</italic>
<sup>f/f</sup> mice, <italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/+</sup> mice and <italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/f</sup> mice. <bold>(D)</bold> Changes (reduction) of rectal temperature at 6 hours following LPS injection in GKO (<italic>Shank3</italic>
<sup>&#x2212;/&#x2212;</sup>) mice and CKO (<italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/f</sup>) mice. <bold>(E)</bold> Serum IL-6 levels in <italic>Shank3</italic>
<sup>f/f</sup> mice and <italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/f</sup> mice treated with LPS. <bold>(F)</bold> Survival curves of three genotypes mice treated with LPS. Data are expressed as mean &#xb1; SEM and analyzed by unpaired two-tailed <italic>t</italic> test <bold>(B, D)</bold>, two-way ANOVA with Bonferroni <italic>post hoc</italic> test <bold>(C, E)</bold>, and Mantel-Cox test <bold>(F)</bold>. <sup>#</sup>
<italic>p</italic> &lt; 0.05, <sup>###</sup>
<italic>p</italic> &lt; 0.001, <sup>####</sup>
<italic>p</italic> &lt; 0.0001 versus baseline. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>**</sup>
<italic>p</italic> &lt; 0.01, <sup>***</sup>
<italic>p</italic> &lt; 0.001, <sup>****</sup>
<italic>p</italic> &lt; 0.0001 versus <italic>Shank3</italic>
<sup>f/f</sup> mice. Sample sizes are indicated in brackets. n.s., not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1124356-g002.tif"/>
</fig>
<p>As in GKO mice, body temperature analysis revealed no difference of basal body temperature between WT and CKO mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>), suggesting that <italic>Shank3</italic> in sensory neurons does not contribute to basal body temperature. We next compared hypothermia phenotypes after LPS injection in three genotypes of WT and CKO mice. Herein, we reported a rapid and transient hyperthermia in <italic>Shank3<sup>f/f</sup>
</italic> mice, as indicated by the elevation in rectal temperature at 30 minutes after LPS injection as compared to baseline (<italic>p</italic> = 0.0473, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). Interestingly, this hyperthermia was completely compromised in both heterozygous and homozygous CKO mice (<italic>p</italic> = 0.0025 and <italic>p</italic> &lt; 0.0001, respectively) when compared with <italic>Shank3<sup>f/f</sup>
</italic> mice. Furthermore, homozygous CKO mice exhibited more rapid (within 1 hour, <italic>p</italic>=0.0038) and more lasting (&gt;48 hours, <italic>p</italic> &lt; 0.0001) hypothermia, as compared to <italic>Shank3<sup>f/f</sup>
</italic> mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>), suggesting that <italic>Shank3</italic> deficiency in sensory neurons accelerates the induction of hypothermia and delays the resolution of hypothermia after sepsis. Intriguingly, sepsis-induced hypothermia was significantly aggravated in both heterozygous and homozygous CKO mice (F (2, 448) = 58.38, <italic>p</italic> &lt; 0.0001, two-way ANOVA, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). There was also significant difference between heterozygous and homozygous CKO mice (F (1, 286) = 16.47, <italic>p</italic> &lt; 0.0001, two-way ANOVA, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). More strikingly, <italic>Shank3</italic> CKO mice exhibited more remarkable changes (reductions) in rectal temperature when compared with <italic>Shank3</italic> GKO (<italic>p</italic> = 0.0136, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>), suggesting a dominant role of peripheral SHANK3 in temperature regulation.</p>
<p>Next, we investigated whether LPS-induced systemic inflammation would also be affected in <italic>Shank3</italic> CKO mice. Serum IL-6 levels did not differ at 3 hours and 6 hours after LPS stimulation in WT and CKO mice. At 24 hours, IL-6 levels returned to baseline in WT mice but remained at the peak in CKO (F (3, 40) = 29.21, <italic>p</italic> = 0.0002, two-way ANOVA, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). Survival rate analysis showed that LPS significantly increased mortality (42.90%) in homozygous CKO mice (p=0.0083, vs. WT, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2F</bold>
</xref>). Collectively, these data demonstrate that SHANK3 in <italic>Nav1.8-</italic>expressing peripheral sensory neurons confers protection against hypothermia, systemic inflammation and septic death after sepsis.</p>
</sec>
<sec id="s3_3">
<title>SHANK3 in peripheral vagal sensory neurons is required for maintaining the homeostasis of core temperature</title>
<p>To investigate a specific role of peripheral SHANK3 in regulating body temperature, we challenged WT and <italic>Shank3</italic> CKO mice in different conditions of hypothermia and hyperthermia, including cold room habituation at 4&#xb0;C (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>), 5% isoflurane anesthesia (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>), intrathecal injection of PGE<sub>2</sub> (200 ng, <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S3</bold>
</xref>), 5% menthol application to the back and auricular region (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>), and auricular application of 100 &#x3bc;M capsaicin (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). Cold room testing showed deficits in homozygous CKO mice (F (1, 60) = 19.49, <italic>p</italic> &lt; 0.0001, two-way ANOVA, vs. WT) and heterozygous CKO mice (F (1, 56) = 5.568, <italic>p</italic> = 0.0168 vs. WT) in maintaining core temperature (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Interestingly, CKO mice exhibited rapid hypothermia compared to WT mice (F (2, 92) = 10.54, <italic>p</italic> &lt; 0.05 vs. WT, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Brief anesthesia to 5% isoflurane produced a rapid drop in body temperature in 10&#xa0;min, but no difference was found between three genotypes (F (2, 42) = 3.094, <italic>p</italic> = 0.0558, two-way ANOVA, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). Intrathecal PGE<sub>2</sub> induced hyperthermia and fever in WT mice, which was impaired in <italic>Shank3</italic> CKO mice (F (2, 48) = 3.835, <italic>p</italic> = 0.0285, two-way ANOVA, <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1</bold>
</xref>). Next, we observed a rapid and transient hyperthermia after 5% menthol smearing in body trunk in <italic>Shank3<sup>f/f</sup>
</italic> mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). This hyperthermia at 30&#xa0;min was partially attenuated in homozygous CKO mice (<italic>p</italic> = 0.0218, vs. WT), although we did not observe any significant difference among three genotypes (F (2, 80) = 1.776, <italic>p</italic> = 0.176, two-way ANOVA, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Next, we smeared 5% menthol to auricular vagal region to mimic vagus nerve stimulation (aVNS, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). This cold/cool stimulation induced hyperthermia in WT mice but not in homozygous CKO mice (F (1, 56) = 12.85, <italic>p</italic> = 0.0007, two-way ANOVA, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>), which was consistent with the results in <italic>Shank3</italic> GKO mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2A</bold>
</xref>). Similarly, aVNS with 100 &#x3bc;M capsaicin smearing produced hyperthermia in <italic>Shank3<sup>f/f</sup>
</italic> mice, which was compromised in both heterozygous and homozygous CKO mice (F (2, 92) = 22.51, <italic>p</italic> &lt; 0.0001, two-way ANOVA, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). The same result was also observed in <italic>Shank3</italic> GKO mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2B</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>
<italic>Shank3</italic> in sensory neurons is required for the maintenance of body temperature after perturbations in C57BL/6 mice. <bold>(A)</bold> Time course of rectal temperature after acute exposure to a cold room (4&#xb0;C) in three genotypes. <bold>(B)</bold> Time course of rectal temperature after brief anesthesia to 5% isoflurane in three genotypes. <bold>(C)</bold> Time course of rectal temperature after 5% menthol smearing on body trunk in <italic>Shank3</italic>
<sup>f/f</sup> mice, <italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/+</sup> mice and <italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/f</sup> mice. <bold>(D)</bold> Time course of rectal temperature after auricular painting of 5% menthol in three genotypes. <bold>(E)</bold> Time course of rectal temperature after auricular painting of 100 &#x3bc;M capsaicin in three genotypes. <bold>(F)</bold> Experimental design for ECG recording after auricular painting of 5% menthol in littermate control WT and CKO mice. <bold>(G)</bold> Representative traces of ECG in <italic>Shank3</italic>
<sup>f/f</sup> mice and <italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/f</sup> mice following vehicle or menthol treatment. <bold>(H)</bold> Heart rate (HR) in <italic>Shank3</italic>
<sup>f/f</sup> mice and <italic>Nav1.8-cre</italic>; <italic>Shank3</italic>
<sup>f/f</sup> mice following vehicle or menthol treatment. Data are expressed as mean &#xb1; SEM and analyzed by two-way or one-way ANOVA with Bonferroni <italic>post hoc</italic> comparisons. <sup>##</sup>
<italic>p</italic> &lt; 0.01, <sup>###</sup>
<italic>p</italic> &lt; 0.001, <sup>####</sup>p &lt; 0.0001, <sup>####</sup>p &lt; 0.0001, versus baseline. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>**</sup>
<italic>p</italic> &lt; 0.01, <sup>***</sup>
<italic>p</italic> &lt; 0.001, <sup>****</sup>
<italic>p</italic> &lt; 0.0001 versus <italic>Shank3</italic>
<sup>f/f</sup> mice. Sample sizes are indicated in brackets. n.s., not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1124356-g003.tif"/>
</fig>
<p>Next, we recorded electrocardiogram (ECG) to assess VNS-induced heart rate (HR) change following auricular menthol smearing (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>). As expected, menthol-induced VNS resulted in a significant decrease of HR in WT <italic>Shank3<sup>f/f</sup>
</italic> mice, which was abolished in homozygous CKO mice (F (1, 14) = 11.73, <italic>p</italic> = 0.0041, two-way ANOVA, <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3G, H</bold>
</xref>). Collectively, these detailed results suggest that peripheral <italic>Shank3</italic> in vagal sensory nerve plays an important role in maintaining core temperature following perturbations.</p>
</sec>
<sec id="s3_4">
<title>Selective SHANK3 knockdown in vagal sensory neurons exacerbates LPS-induced hypothermia, systemic inflammation and mortality</title>
<p>SHANK3 is expressed by different types of peripheral sensory neurons in mouse DRG, NG, and trigeminal ganglia (<xref ref-type="bibr" rid="B34">34</xref>). To confirm a specific role of peripheral SHANK3 in vagal nerve for regulating the LPS-induced effects, we used <italic>Shank3</italic> siRNA to knockdown endogenous SHANK3 expression in vagal sensory neurons in NG. A short peptide derived from rabies virus glycoprotein (RVG) has been utilized to facilitate siRNA uptake by neurons including sensory neurons and enhance knockdown efficiency of siRNA (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). We performed bilateral peri-vagal nerve delivery of <italic>Shank3</italic> siRNA (mixed with the RVG peptide, 1:10) in CD1 mice (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). <italic>In situ</italic> hybridization (ISH) revealed a profound reduction in <italic>Shank3</italic> mRNA in NG neurons following <italic>Shank3</italic> siRNA (100 nM) treatment (F (2, 9) = 48.70, <italic>p</italic> = 0.0002, one-way ANOVA, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>), suggesting the successful establishment of SHANK3 knockdown by siRNA. We next challenged these mice with LPS on 3 days following siRNA injection. Intriguingly, we found that LPS-induced transient hyperthermia in control siRNA treated mice was completely lost after <italic>Shank3</italic> siRNA treatment (<italic>p</italic> &lt; 0.0001, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Moreover, LPS-induced hypothermia was significantly aggravated by vagal SHANK3 knockdown (F (1, 75) = 90.52, <italic>p</italic> &lt; 0.0001, two-way ANOVA, vs. control siRNA, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Peri-vagal <italic>Shank3</italic> siRNA (50 nM, 100 nM and 200 nM) enhanced LPS-induced hypothermia in a dose-dependent manner (F (5, 297) = 53.45, <italic>p</italic> &lt; 0.0001, two-way ANOVA, <xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S3A</bold>
</xref>). Furthermore, we detected a robust increase of serum IL-6 levels at 3 hours after LPS injection (<italic>p</italic> = 0.0027, <italic>Shank3</italic> siRNA vs. control siRNA, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). However, we did not detect any difference of mortality between control siRNA and <italic>Shank3</italic> siRNA treatment, as CD1 mice are more resistant to sepsis than C57BL/6 mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figures S3B&#x2013;D</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>SHANK3 knockdown in vagal sensory neurons aggravates LPS-induced hypothermia, systemic inflammation and mortality in CD1 mice <bold>(A&#x2013;D)</bold> and C57BL/6 mice <bold>(E&#x2013;G)</bold>. <bold>(A)</bold> Experimental design for SHANK3 knockdown, LPS injection, body temperature measurement and blood collection in CD1 mice. Peri-neural injection of 100 nM <italic>Shank3</italic> siRNA (5 &#x3bc;l, mixed with RVG peptide, 1:10) was made to knockdown SHANK3 expression in vagal sensory neurons in NG. <bold>(B)</bold> ISH images showing <italic>Shank3</italic> mRNA (red) expression in NG following control siRNA and <italic>Shank3</italic> siRNA treatment. Scale bar, 50 &#x3bc;m. <bold>(C)</bold> Time course of rectal temperature after LPS injection (1mg/kg, i.p.) in control siRNA and <italic>Shank3</italic> siRNA treated mice. <bold>(D)</bold> Serum IL-6 levels after LPS exposure in control siRNA and <italic>Shank3</italic> siRNA treated mice. <bold>(E)</bold> Experimental design for SHANK3 knockdown, LPS injection, body temperature measurement and blood collection in <italic>Shank3</italic>
<sup>f/f</sup> mice. Peri-neural AAV9-Cre virus injection was made to knockdown SHANK3 expression in vagal sensory neurons in NG in <italic>Shank3</italic>
<sup>f/f</sup> mice. <bold>(F)</bold> Time course of rectal temperature after LPS (1mg/kg) injection in AAV9 control virus and AAV9 <italic>Cre</italic> virus treated mice. <bold>(G)</bold> Serum IL-6 levels and <bold>(H)</bold> Survival curves after LPS exposure in AAV9 control virus and AAV9 <italic>Cre</italic> virus treated mice. Data are expressed as mean &#xb1; SEM and analyzed by one-way ANOVA with Bonferroni <italic>post hoc</italic> test <bold>(B)</bold>, two-way ANOVA with Bonferroni <italic>post hoc</italic> test <bold>(C, D, F, G)</bold>, and Mantel-Cox test <bold>(H)</bold>. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>**</sup>
<italic>p</italic> &lt; 0.01, <sup>***</sup>
<italic>p</italic> &lt; 0.001, <sup>****</sup>
<italic>p</italic> &lt; 0.0001 versus mice treated control siRNA or AAV9 control virus. Sample sizes are indicated in brackets. n.s., not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1124356-g004.tif"/>
</fig>
<p>Next, we employed GFP fluorescence-labeled AAV9-<italic>Cre</italic> virus to produce a more persistent knockdown of endogenous SHANK3 expression in vagal sensory neurons, by using bilateral peri-vagal nerve delivery of AAV9 <italic>Cre</italic> virus in <italic>Shank3<sup>f/f</sup>
</italic> mice (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>). Peri-vagal nerve injection of GFP-labeled AAV9 <italic>Cre</italic> virus resulted in uptake of AAV9 <italic>Cre</italic> virus in NG neurons as a result of axonal transport from the vagal nerve (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S4A</bold>
</xref>). Simultaneously, we detected a profound reduction in <italic>Shank3</italic> mRNA in NG neurons following the same treatment (<italic>p</italic> = 0.0002, <xref ref-type="supplementary-material" rid="SM1">
<bold>Figures S4A&#x2013;C</bold>
</xref>), manifesting the successful establishment of SHANK3 knockdown by <italic>Cre</italic> virus in <italic>Shank3<sup>f/f</sup>
</italic> mice. We next challenged these mice with LPS at 2 weeks following the virus injection. We found that the <italic>Cre</italic> virus treatment abolished the LPS-induced transient hyperthermia (<italic>p</italic>&#xa0;= 0.002 vs. control virus) and exacerbated the LPS-induced hypothermia (F (1, 89) = 36.12, <italic>p</italic> &lt; 0.0001, two-way ANOVA, vs. control virus, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>). Moreover, the <italic>Shank3</italic> virus treated mice exhibited a significant increase of serum IL-6 levels (F (1, 24) = 10.18, <italic>p</italic> = 0.0039, Two-Way ANOVA, vs. control virus, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4G</bold>
</xref>) following LPS challenge. Vagal SHANK3 knockdown by <italic>Cre</italic> virus treatment also resulted in a significant reduction in survival rate after LPS intervention in <italic>Shank3<sup>f/f</sup>
</italic> mice (<italic>p</italic> = 0.0274, vs. control virus, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4H</bold>
</xref>). Collectively, these data indicate that SHANK3 in vagal sensory neurons confers protection against LPS-induced hypothermia, systemic inflammation and septic death.</p>
</sec>
<sec id="s3_5">
<title>SHANK3 regulates core temperature and systemic inflammation <italic>via</italic> TRPM2</title>
<p>TRP channels are thermosensors in peripheral nervous system and detect ambient temperature changes (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). First, we employed quantitative RT-PCR to measure mRNA expressions of <italic>Trpm2, Trpv1, Trpv4, Trpm8</italic> and <italic>Scn10A</italic> (encoding Nav1.8) in NG of WT and GKO mice. Interestingly, we detected a robust reduction in <italic>Trpm2</italic> (<italic>p</italic> = 0.00754) but not <italic>Trpv1, Trpv4, Trpm8</italic> and <italic>Scn10A</italic> mRNA levels in NG of <italic>Shank3</italic>
<sup>&#x2212;/&#x2212;</sup> mice (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). ISH revealed a broad expression of <italic>Trpm2</italic> mRNA in majority of NG neurons in WT mice, but this expression was significantly lower in <italic>Shank3</italic>
<sup>&#x2212;/&#x2212;</sup> mice (<italic>p</italic> &lt; 0.05, vs. WT, <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>SHANK3 regulates body temperature and inflammation <italic>via</italic> TRPM2 in C57BL/6 mice <bold>(A, B)</bold> and CD1 mice <bold>(C&#x2013;G)</bold>. <bold>(A)</bold> RT-PCR analysis showing the expression of <italic>Trpm2, Trpv1, Trpv4, Trpm8</italic> and <italic>Scn10A</italic> in NG of WT mice and <italic>Shank3</italic>
<sup>&#x2212;/&#x2212;</sup> mice. <bold>(B)</bold> ISH images showing <italic>Trpm2</italic> mRNA expression in NG neurons of WT mice and <italic>Shank3</italic>
<sup>&#x2212;/&#x2212;</sup> mice. Scale bar, 50 &#x3bc;m. Right, quantification of <italic>Shank3</italic> mRNA levels. <sup>*</sup>
<italic>p</italic> &lt; 0.05. <bold>(C)</bold> Experimental design for TRPM2 knockdown, LPS injection, body temperature measurement and blood collection in CD1 mice. Peri-neural injection of 100 nM <italic>Trpm2</italic> siRNA was made to knockdown TRPM2 expression in NG neurons. <bold>(D)</bold> ISH images showing <italic>Trpm2</italic> mRNA expression in NG neurons following control siRNA and <italic>Trpm2</italic> siRNA injection. Scale bar, 50 &#x3bc;m. Right, quantification of <italic>Trpm2</italic> mRNA levels. <sup>*</sup>
<italic>p</italic> &lt; 0.05. <bold>(E)</bold> Time course of rectal temperature after LPS injection (1mg/kg, i.p.) in control siRNA and <italic>Trpm2</italic> siRNA treated mice. <bold>(F)</bold> Serum IL-6 levels and <bold>(G)</bold> survival curves after LPS exposure in control siRNA and <italic>Trpm2</italic> siRNA treated mice. Data are expressed as mean &#xb1; SEM and analyzed by unpaired two-tailed <italic>t</italic> test <bold>(B, D)</bold>, two-way ANOVA with Bonferroni <italic>post hoc</italic> test <bold>(E, F)</bold>, and Mantel-Cox test <bold>(G)</bold>. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>***</sup>
<italic>p</italic> &lt; 0.001, <sup>****</sup>
<italic>p</italic> &lt; 0.0001 versus WT mice or mice treated control siRNA. Sample sizes are indicated in brackets. ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1124356-g005.tif"/>
</fig>
<p>To further verify the potential role of peripheral TRPM2 in vagal nerve in sepsis-induced hypothermia, <italic>Trpm2</italic> siRNA (100 nM) was employed to knockdown endogenous TRPM2 expression in vagal sensory neurons of CD1 mice through bilateral peri-vagal nerve delivery (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). ISH detected a significant reduction in <italic>Trpm2</italic> mRNA in NG neurons following the siRNA treatment (<italic>p</italic> = 0.01331, <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). Following LPS challenge, <italic>Trpm2</italic> siRNA treatment exacerbated hypothermia (F (1, 150) = 120.4, <italic>P</italic> &lt; 0.0001, vs. control siRNA, <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>) and increased serum IL-6 levels (F (1, 39) = 39.31, <italic>p</italic> &lt; 0.0001, vs. control siRNA, <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5F</bold>
</xref>), without affecting mortality in CD1 mice (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5G</bold>
</xref>). Together, these data indicate that 1) TRPM2 is a downstream event of SHANK3 signaling in NG neurons and 2) loss of TRPM2 in vagal sensory neurons can recapitulate some of the key features of SHANK3 knockdown, including hypothermia and systemic IL-6 increase.</p>
</sec>
<sec id="s3_6">
<title>SHANK2 or TRPV1 deficiency in peripheral sensory neurons fails to alter body temperature homeostasis and systemic inflammation</title>
<p>Dysfunction of SHANK2 protein is also a critical step for the development of autistic-like behaviors (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B37">37</xref>). We therefore investigated whether SHANK2 is involved in LPS and menthol induced thermal regulation using <italic>Shank2</italic> CKO mice with <italic>Shank2</italic> deletion in Nav1.8<sup>+</sup> sensory neurons. We did not find significant differences in LPS-induced hypothermia (F (2, 124) = 0.1497, <italic>p</italic> = 0.8611, two-way ANOVA, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>) and survival rate (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S5A</bold>
</xref>) between littermate control mice (<italic>Shank2<sup>f/f</sup>
</italic>) and CKO mice (<italic>Nav1.8-cre; Shank2<sup>f/+</sup>
</italic> and <italic>Nav1.8-cre; Shank2<sup>f/f</sup>
</italic>). In parallel, we did not observe significant differences in menthol-induced hyperthermia (F (2, 64) = 0.3973, <italic>p</italic> = 0.6738, two-way ANOVA, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>), capsaicin-induced hyperthermia (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S5B</bold>
</xref>), and anesthesia-induced hypothermia (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S5C</bold>
</xref>). Thus, <italic>Shank2</italic> in peripheral sensory neurons is not involved in the regulation of body core temperature.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>SHANK2 and TRPV1 are dispensable in LPS-induced hypothermia and systemic inflammation in C57BL/6 mice. <italic>Shank2</italic> conditional knockout mice were generated by crossing <italic>Shank2</italic>-floxed mice with <italic>Nav1.8</italic>-<italic>Cre</italic> mice, leading to specific loss of <italic>Shank2</italic> in Nav1.8-expressing sensory neurons. <bold>(A)</bold> Time course of rectal temperature after LPS injection (1mg/kg, i.p.) in <italic>Shank2</italic>
<sup>f/f</sup> mice, <italic>Nav1.8-cre</italic>; <italic>Shank2</italic>
<sup>f/+</sup> mice and <italic>Nav1.8-cre</italic>; <italic>Shank2</italic>
<sup>f/f</sup> mice. <bold>(B)</bold> Time course of rectal temperature after auricular painting of 5% menthol in <italic>Shank2</italic>
<sup>f/f</sup> mice, <italic>Nav1.8-cre</italic>; <italic>Shank2</italic>
<sup>f/+</sup> mice and <italic>Nav1.8-cre</italic>; <italic>Shank2</italic>
<sup>f/f</sup> mice. <bold>(C)</bold> Peri-neural injection of 100 nM <italic>Trpv1</italic> siRNA was made to knockdown TRPV1 expression in vagal sensory neurons in NG. ISH images showing <italic>Trpv1</italic> mRNA (red) expression in NG neurons following control siRNA and <italic>Trpv1</italic> siRNA injection. Scale bar, 50 &#x3bc;m. ****<italic>p</italic> &lt; 0.0001, unpaired t-test. <bold>(D)</bold> Time course of rectal temperature after LPS injection (1mg/kg, (i) p.) in control siRNA and <italic>Trpv1</italic> siRNA treated mice. <bold>(E)</bold> Serum IL-6 levels after LPS exposure in control siRNA and <italic>Trpv1</italic> siRNA treated mice. Data are expressed as mean &#xb1; SEM and analyzed by two-way or one-way ANOVA with Bonferroni <italic>post hoc</italic> test. Sample sizes are indicated in brackets. Not significant, n.s. ****<italic>p</italic> &lt; 0.0001 versus naive mice.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1124356-g006.tif"/>
</fig>
<p>Given a functional link between SHANK3 and TRPV1 in DRG primary sensory neurons and heat sensation (<xref ref-type="bibr" rid="B24">24</xref>), we evaluated whether peripheral TRPV1 is important for sepsis-induced hypothermia. <italic>Trpv1</italic> siRNA was employed to knockdown endogenous TRPV1 expression in NG neurons <italic>via</italic> peri-vagal nerve delivery in CD1 mice. ISH detected a substantial reduction in <italic>Trpv1</italic> mRNA in NG neurons following <italic>Trpv1</italic> siRNA (100 nM) injection [F (2, 9) = 115.8, <italic>p</italic> &lt; 0.0001, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>]. Compared to the control siRNA, <italic>Trpv1</italic> siRNA had no significant effects on LPS-induced hypothermia (F (1, 70) = 0.648, <italic>p</italic> = 0.4235, two-way ANOVA, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>) and serum expressions of IL-6 (F (1, 18) = 0.3131, <italic>p</italic> = 0.5827, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>). These findings suggest that TRPV1 in vagal sensory neurons is not required for sepsis-induced hypothermia, systemic inflammation, and mortality.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>In this study, using <italic>Shank3</italic> complete knockout mice with deletion of exons 4 to 22 (&#x394;e4-22 <italic>Shank3</italic>
<bold>
<sup>&#x2500;/&#x2500;</sup>
</bold>) (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B24">24</xref>), we have made several interesting findings. First, SHANK3 is broadly expressed in vagal sensory neurons in NG. Second, <italic>Shank3</italic> regulates <italic>Trpm2</italic> expression in vagal sensory neurons. Third, <italic>Shank3</italic> deficiency, but not <italic>Shank2</italic> and <italic>Trpv1</italic> deficiency, exacerbates hypothermia, systemic inflammation (serum IL-6 levels), and mortality in mice, induced by a low dose of lipopolysaccharide (1 mg/kg). Fourth, <italic>Shank3</italic> CKO mice with <italic>Shank3</italic> deficiency in Nav1.8-expressing sensory neurons can recapitulate all these detrimental effects of LPS in GKO mice. Strikingly, selective knockdown of <italic>Shank3</italic> or <italic>Trpm2</italic> in vagal sensory neurons is sufficient to mediate these actions of SHANK3. Our study highlights a novel role of vagal sensory neurons in mediating SHANK3-dependent disorders.</p>
<p>Mutations in the <italic>SHANK3</italic> gene have been recognized as a genetic risk factor for ASD (<xref ref-type="bibr" rid="B2">2</xref>). Notably, heterozygous <italic>SHANK3</italic> mutations are typically associated with idiopathic ASD in patients, but heterozygous deletion of <italic>Shank3</italic> gene in mice does not commonly induce ASD-related behavioral deficit (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Using &#x25b3;e4-22 <italic>Shank3</italic> full knockout strategy, <italic>Shank3</italic> haploinsufficiency was sufficient to cause marked deficits in TRPV1-medicated heat pain. These pain deficits were fully recapitulated in <italic>Shank3</italic>
<sup>+/-</sup> CKO mice with <italic>Shank3</italic> deficiency in sensory neurons (<xref ref-type="bibr" rid="B24">24</xref>). In the present study, <italic>Shank3</italic>
<sup>+/-</sup> GKO and CKO mice also exhibited significant deficits in LPS-induced hypothermia and systemic inflammation, albeit <italic>Shank3</italic>
<sup>-/-</sup> GKO and CKO mice had more robust phenotypes. Furthermore, genetically vulnerable <italic>Shank3</italic>
<sup>+/-</sup> mice, when challenged with LPS to induce an acute inflammatory response, showed robust circuit and behavioral alterations related to ASD (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>Apart from genetic risk factors, studies also support the hypothesis of immune dysregulation in ASD (<xref ref-type="bibr" rid="B3">3</xref>). Especially, IL-6 and IL-17 were upregulated in ASD individuals or animal models of ASD and contribute to autistic behaviors in animal models (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>). Furthermore, blocking these cytokines with neutralizing antibodies were shown to alleviate autistic behaviors (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Frequent respiratory infections were found in 57% of ASD patients and regarded as an ASD comorbidity (<xref ref-type="bibr" rid="B4">4</xref>). Devastating symptoms were reported in some PMS patients after acute infections or stressful environmental challenges (<xref ref-type="bibr" rid="B38">38</xref>). Several clinical studies reported improvements in ASD behaviors following antibiotic treatments (<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>) and immunomodulation (<xref ref-type="bibr" rid="B19">19</xref>). Low dose LPS challenge (1-2 mg/kg) induces systemic inflammation (&#x201c;cytokine storm&#x201d;) and neuroinflammation and exacerbates ASD symptoms in <italic>Shank3</italic>
<sup>+/-</sup> mice (<xref ref-type="bibr" rid="B7">7</xref>). We found that IL-6 is significantly dysregulated (upregulated) after <italic>Shank3</italic> deficiency, in response to LPS challenge. It will be of great interest to examine the changes of these cytokines in the brain and CSF, which could drive some ASD symptoms.</p>
<p>Accumulating evidence suggests that the vagus system plays a critical role in regulating the gut-brain axis (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>), and dysregulation of this axis contributes to ASD (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Microbial-based therapy has been used to treat social deficits in mouse models of ASD and the vagus nerve is required for this therapeutic effect in <italic>Shank3B</italic> knockout mice (<xref ref-type="bibr" rid="B20">20</xref>). VNS is a safe and effective therapy for pediatric patients with drug-resistant epilepsy. There is some evidence that VNS, when performed for epilepsy, may improve behavior in ASD individuals (<xref ref-type="bibr" rid="B39">39</xref>). An observational study revealed that VNS not only controlled epilepsy but also improved the autistic behaviors, especially in language, social and self-help (<xref ref-type="bibr" rid="B40">40</xref>). It appears that this behavioral improvement occurs independently of VNS&#x2019; modulation of seizure (<xref ref-type="bibr" rid="B39">39</xref>). Our findings suggest that SHANK3 in vagal sensory neurons may regulate vagal activity. One important vagal regulation is to regulate heart rate. However, this regulatory function of the vagus nerve is impaired after <italic>Shank3</italic> deficiency. This notion is supported by our ECG data demonstrating that auricular VNS reduced heart rate in WT mice but not in <italic>Shank3</italic> KO mice. Vagus nerve regulates the hemostasis of various physiological functions in our body, including body temperature and inflammation. VNS and peripheral nerve stimulation (e.g., acupuncture) confer protection against LPS-induced hypothermia, systemic inflammation, and septic death (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>).</p>
<p>Using sensitive RNAscope ISH, we revealed broad expression of <italic>Shank3</italic> mRNA in majority of NG neurons. Importantly, selective knockdown of <italic>Shank3</italic> by siRNA and AAV Cre virus, <italic>via</italic> a perineural delivery approach (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>), was sufficient to produce the phenotypes (hypothermia and excessive inflammation) in <italic>Shank3</italic> GKO and CKO mice. To our knowledge this is the first report to demonstrate the function of <italic>Shank3</italic> in vagal sensory neurons. Single-cell RNAseq showed low level expression of <italic>Shank3</italic> in some vagal sensory neurons (<xref ref-type="bibr" rid="B43">43</xref>). Earlier study showed that SHANK3 expression in primary sensory neurons regulates thermal pain and heat hyperalgesia (<xref ref-type="bibr" rid="B24">24</xref>). As a scaffold protein, SHANK3 interacts with TRPV1 and regulates the surface expression of this heat sensor. Thus, capsaicin-induced cellular responses and pain were largely abolished in mice with <italic>Shank3</italic> deficiency (<xref ref-type="bibr" rid="B24">24</xref>). NG sensory neurons also express multiple TRP channels, including TRPV1, TRPA1, TRPM8, and TRPM2 (<xref ref-type="bibr" rid="B43">43</xref>). Interestingly, <italic>Shank3</italic> deficiency resulted in reduced expression of <italic>Trpm2</italic>, without changing the expression of <italic>Trpv1</italic>, <italic>Trpv4</italic>, <italic>Trpm8</italic>, and <italic>SCN10A</italic> (encoding Nav1.8). This raises a possibility of transcriptional regulation of <italic>Trpm2</italic> by SHANK3. Interestingly, SHANK3 was found in the nuclei of primary sensory neurons (<xref ref-type="bibr" rid="B24">24</xref>). Future studies are needed to investigate how SHANK3 regulates the transcription of <italic>Trpm2</italic>. TRPM2 is a non-selective cation channel. In hypothalamic neurons, TRPM2 channel is a heat sensor. TRPM2 in hypothalamus can limit fever and drive hypothermia (<xref ref-type="bibr" rid="B44">44</xref>). TRPM2 is also expressed abundantly in immune cells and is important in inflammatory processes (<xref ref-type="bibr" rid="B45">45</xref>). Especially, TRPM2 acts as an oxidant sensor and oxidant sensing by TRPM2 inhibits neutrophil migration and mitigates inflammation (<xref ref-type="bibr" rid="B46">46</xref>). We speculate that TRPM2 in vagal sensory neurons could sense the LPS-induced inflammatory oxidants (e.g., ROS). Thus, activation of TRPM2 by stress and oxidants in NG neurons will result in calcium influx and activation of vagal sensory neurons to mediate the anti-inflammatory actions of the VNS. It is noteworthy that basal body temperature under the non-stressful normal conditions does not require <italic>Shank3</italic> and <italic>Trmp2</italic> in vagal sensory neurons. However, SHANK3 or/and TRPM2 play an important role in maintaining body temperature, under stressful conditions with temperature perturbations, such as LPS challenge, VNS by auricular application of menthol and capsaicin, cold environment, and PGE2-induced fever.</p>
<p>Our results also showed that <italic>Shank3</italic> deficiency in GKO and CKO mice or <italic>Shank3</italic> knockdown in vagal sensory neurons lead to increased mortality in response to systemic LPS challenge (1 mg/kg, i.p.). This low-dose LPS challenge produced very low mortality (10%) in WT mice but resulted in 50% mortality in global and conditional <italic>Shank</italic> <sup>-/-</sup> mice. This septic death after <italic>Shank3</italic> deficiency may result from a substantial loss of body temperature (hypothermia, &lt;32&#xb0;C body temperature was closely associated with septic death) and excessive inflammation by cytokine storm. LPS-induced IL-6 upregulation is highly correlated to septic death (<xref ref-type="bibr" rid="B28">28</xref>). Among the inflammatory cytokines we measured in this study, only IL-6 is significantly dysregulated after <italic>Shank3</italic> and <italic>Trpm2</italic> deficiency, in response to LPS challenge. A recent study in 2021 was conducted in 9754 autism pupils in Scotland, which is 1.2% out of 787,666 pupils examined. The authors cautiously concluded that the death rate in the current generation of children and young adults with autism is no higher than for other children, in part due to improved diagnosis and care (<xref ref-type="bibr" rid="B47">47</xref>). It is noteworthy that ASD children with <italic>SHANK3</italic> mutations exhibit frequent respiratory infections in 57% cases (<xref ref-type="bibr" rid="B4">4</xref>). It will be of great interest to study if individuals with <italic>SHANK3</italic> mutations have a higher risk of mortality than ASD individuals with other genetic mutations.</p>
<p>In summary, our findings demonstrate a novel role of SHANK3 in vagal sensory neurons in maintaining body temperature after stress-related perturbations. Furthermore, vagal SHANK3 can limit excessive inflammation after LPS challenge, offering new molecular insights into inflammation dysregulation in some ASD individuals. Finally, we provided a novel link between SHANK3 and TRPM2, an oxidant/stress sensor, in vagal sensory neurons. Recent study connected SHANK to TRPV4 in the Nucleus Accumbens, as TRPV4 inhibition could alleviate autistic behaviors in Shank3<sup>+/-</sup> mice (<xref ref-type="bibr" rid="B7">7</xref>). It remains to be investigated whether impairment of SHANK3-medated vagal modulation is sufficient to drive behavioral changes in ASD, moreover, whether TRPM2 agonist can improve the ASD symptoms.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by Duke University IACUC.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>LZ, SB and R-RJ designed research; LZ, SB, QH, MM, and XL performed research and analyzed data; LZ, SB, Y-HJ and R-RJ wrote the manuscript and other authors edited the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This study is supported by Duke University Anesthesiology Research Funds and NIH R01grant DE17794. Y-HJ is supported by R01 MH117289 and R01HD088007.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2023.1124356/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2023.1124356/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Table_1.xlsx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaiser</surname> <given-names>T</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Modeling psychiatric disorders for developing effective treatments</article-title>. <source>Nat Med</source> (<year>2015</year>) <volume>21</volume>:<page-range>979&#x2013;88</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nm.3935</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Ehlers</surname> <given-names>MD</given-names>
</name>
</person-group>. <article-title>Modeling autism by SHANK gene mutations in mice</article-title>. <source>Neuron</source> (<year>2013</year>) <volume>78</volume>:<fpage>8</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.016</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azhari</surname> <given-names>A</given-names>
</name>
<name>
<surname>Azizan</surname> <given-names>F</given-names>
</name>
<name>
<surname>Esposito</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>A systematic review of gut-immune-brain mechanisms in autism spectrum disorder</article-title>. <source>Dev Psychobiol</source> (<year>2019</year>) <volume>61</volume>:<page-range>752&#x2013;71</page-range>. doi: <pub-id pub-id-type="doi">10.1002/dev.21803</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Altered striatum centered brain structures in SHANK3 deficient Chinese children with genotype and phenotype profiling</article-title>. <source>Prog Neurobiol</source> (<year>2021</year>) <volume>200</volume>:<fpage>101985</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pneurobio.2020.101985</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orefice</surname> <given-names>LL</given-names>
</name>
</person-group>. <article-title>Outside-in: Rethinking the etiology of autism spectrum disorders</article-title>. <source>Science</source> (<year>2019</year>) <volume>366</volume>:<page-range>45&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.aaz3880</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarasua</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Boccuto</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sharp</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Dwivedi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>CF</given-names>
</name>
<name>
<surname>Rollins</surname> <given-names>JD</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinical and genomic evaluation of 201 patients with phelan-McDermid syndrome</article-title>. <source>Hum.Genet</source> (<year>2014</year>) <volume>133</volume>:<page-range>847&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00439-014-1423-7</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tzanoulinou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Musardo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Contestabile</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bariselli</surname> <given-names>S</given-names>
</name>
<name>
<surname>Casarotto</surname> <given-names>G</given-names>
</name>
<name>
<surname>Magrinelli</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of Trpv4 rescues circuit and social deficits unmasked by acute inflammatory response in a Shank3 mouse model of autism</article-title>. <source>Mol Psychiatry</source> (<year>2022</year>) <volume>27</volume>:<page-range>2080&#x2013;94</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41380-021-01427-0</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Bey</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Katz</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Badea</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>N</given-names>
</name>
<name>
<surname>David</surname> <given-names>LK</given-names>
</name>
<etal/>
</person-group>. <article-title>Altered mGluR5-homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism</article-title>. <source>Nat Commun</source> (<year>2016</year>) <volume>7</volume>:<fpage>11459</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms11459</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peca</surname> <given-names>J</given-names>
</name>
<name>
<surname>Feliciano</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ting</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wells</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Venkatraman</surname> <given-names>TN</given-names>
</name>
<etal/>
</person-group>. <article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>. <source>Nature</source> (<year>2011</year>) <volume>472</volume>:<page-range>437&#x2013;42</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature09965</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chauhan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sheikh</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Patil</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chauhan</surname> <given-names>V</given-names>
</name>
<name>
<surname>Li</surname> <given-names>XM</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated immune response in the brain of autistic patients</article-title>. <source>J Neuroimmunol</source> (<year>2009</year>) <volume>207</volume>:<page-range>111&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.12.002</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jyonouchi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>S</given-names>
</name>
<name>
<surname>Le</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression</article-title>. <source>J Neuroimmunol</source> (<year>2001</year>) <volume>120</volume>:<page-range>170&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0165-5728(01)00421-0</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Quintana</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Glozier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lloyd</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Hickie</surname> <given-names>IB</given-names>
</name>
<name>
<surname>Guastella</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis</article-title>. <source>Mol Psychiatry</source> (<year>2015</year>) <volume>20</volume>:<page-range>440&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1038/mp.2014.59</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Garbett</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mirnics</surname> <given-names>K</given-names>
</name>
<name>
<surname>Patterson</surname> <given-names>PH</given-names>
</name>
</person-group>. <article-title>Maternal immune activation alters fetal brain development through interleukin-6</article-title>. <source>J Neurosci</source> (<year>2007</year>) <volume>27</volume>:<page-range>10695&#x2013;702</page-range>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2178-07.2007</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>GB</given-names>
</name>
<name>
<surname>Yim</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SV</given-names>
</name>
<etal/>
</person-group>. <article-title>The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring</article-title>. <source>Science</source> (<year>2016</year>) <volume>351</volume>:<page-range>933&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.aad0314</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yim</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Ha</surname> <given-names>S</given-names>
</name>
<name>
<surname>Atarashi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>TG</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring</article-title>. <source>Nature</source> (<year>2017</year>) <volume>549</volume>:<page-range>528&#x2013;32</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature23910</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandler</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Finegold</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Bolte</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Buchanan</surname> <given-names>CP</given-names>
</name>
<name>
<surname>Maxwell</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Vaisanen</surname> <given-names>ML</given-names>
</name>
<etal/>
</person-group>. <article-title>Short-term benefit from oral vancomycin treatment of regressive-onset autism</article-title>. <source>J Child Neurol</source> (<year>2000</year>) <volume>15</volume>:<page-range>429&#x2013;35</page-range>. doi: <pub-id pub-id-type="doi">10.1177/088307380001500701</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urbano</surname> <given-names>M</given-names>
</name>
<name>
<surname>Okwara</surname> <given-names>L</given-names>
</name>
<name>
<surname>Manser</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hartmann</surname> <given-names>K</given-names>
</name>
<name>
<surname>Herndon</surname> <given-names>A</given-names>
</name>
<name>
<surname>Deutsch</surname> <given-names>SI</given-names>
</name>
</person-group>. <article-title>A trial of d-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder</article-title>. <source>Clin Neuropharmacol</source> (<year>2014</year>) <volume>37</volume>:<fpage>69</fpage>&#x2013;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1097/WNF.0000000000000033</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vuong</surname> <given-names>HE</given-names>
</name>
<name>
<surname>Hsiao</surname> <given-names>EY</given-names>
</name>
</person-group>. <article-title>Emerging roles for the gut microbiome in autism spectrum disorder</article-title>. <source>Biol Psychiatry</source> (<year>2017</year>) <volume>81</volume>:<page-range>411&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2016.08.024</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bey</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Gorman</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Gallentine</surname> <given-names>W</given-names>
</name>
<name>
<surname>Kohlenberg</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Frankovich</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>YH</given-names>
</name>
<etal/>
</person-group>. <article-title>Subacute neuropsychiatric syndrome in girls with SHANK3 mutations responds to immunomodulation</article-title>. <source>Pediatrics</source> (<year>2020</year>) <volume>145</volume>:<elocation-id>e20191490</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1542/peds.2019-1490</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sgritta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dooling</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Buffington</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Momin</surname> <given-names>EN</given-names>
</name>
<name>
<surname>Francis</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Britton</surname> <given-names>RA</given-names>
</name>
<etal/>
</person-group>. <article-title>Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder</article-title>. <source>Neuron</source> (<year>2019</year>) <volume>101</volume>:<fpage>246</fpage>&#x2013;<lpage>59.e6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2018.11.018</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buffington</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Di Prisco</surname> <given-names>GV</given-names>
</name>
<name>
<surname>Auchtung</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Ajami</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Petrosino</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Costa-Mattioli</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring</article-title>. <source>Cell</source> (<year>2016</year>) <volume>165</volume>:<page-range>1762&#x2013;75</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2016.06.001</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tracey</surname> <given-names>KJ</given-names>
</name>
</person-group>. <article-title>The inflammatory reflex</article-title>. <source>Nature</source> (<year>2002</year>) <volume>420</volume>:<page-range>853&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature01321</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>QJ</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>RB</given-names>
</name>
</person-group>. <article-title>Vagal sensory neurons and gut-brain signaling</article-title>. <source>Curr Opin Neurobiol</source> (<year>2020</year>) <volume>62</volume>:<page-range>133&#x2013;40</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.conb.2020.03.006</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>ZJ</given-names>
</name>
<name>
<surname>Bey</surname> <given-names>AL</given-names>
</name>
<etal/>
</person-group>. <article-title>SHANK3 deficiency impairs heat hyperalgesia and TRPV1 signaling in primary sensory neurons</article-title>. <source>Neuron</source> (<year>2016</year>) <volume>92</volume>(<issue>6</issue>):<page-range>1279&#x2013;93</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.007</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orefice</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Mosko</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Morency</surname> <given-names>DT</given-names>
</name>
<name>
<surname>Wells</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Tasnim</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mozeika</surname> <given-names>SM</given-names>
</name>
<etal/>
</person-group>. <article-title>Targeting peripheral somatosensory neurons to improve tactile-related phenotypes in ASD models</article-title>. <source>Cell</source> (<year>2019</year>) <volume>178</volume>:<fpage>867</fpage>&#x2013;<lpage>86.e24</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2019.07.024</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bey</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>N</given-names>
</name>
<name>
<surname>Passman</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Brain region-specific disruption of Shank3 in mice reveals a dissociation for cortical and striatal circuits in autism-related behaviors</article-title>. <source>Transl Psychiatry</source> (<year>2018</year>) <volume>8</volume>(<issue>1</issue>):<fpage>94</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41398-018-0142-6</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname> <given-names>N</given-names>
</name>
<name>
<surname>Offermanns</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kuner</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia</article-title>. <source>Genesis</source> (<year>2004</year>) <volume>38</volume>:<page-range>122&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1002/gene.20010</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Donnelly</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>X</given-names>
</name>
<name>
<surname>Toro-Moreno</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice</article-title>. <source>Nat Commun</source> (<year>2021</year>) <volume>12</volume>:<fpage>1704</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-21940-8</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berta</surname> <given-names>T</given-names>
</name>
<name>
<surname>Park</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>ZZ</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Extracellular caspase-6 drives murine inflammatory pain <italic>via</italic> microglial TNF-alpha secretion</article-title>. <source>J Clin Invest</source> (<year>2014</year>) <volume>124</volume>:<page-range>1173&#x2013;86</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI72230</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>P</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<name>
<surname>McBride</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Davidson</surname> <given-names>BL</given-names>
</name>
<etal/>
</person-group>. <article-title>Transvascular delivery of small interfering RNA to the central nervous system</article-title>. <source>Nature</source> (<year>2007</year>) <volume>448</volume>:<fpage>39</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature05901</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zanos</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Silverman</surname> <given-names>HA</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tsaava</surname> <given-names>T</given-names>
</name>
<name>
<surname>Battinelli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lorraine</surname> <given-names>PW</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of cytokine-specific sensory neural signals by decoding murine vagus nerve activity</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2018</year>) <volume>115</volume>:<page-range>E4843&#x2013;52</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1719083115</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname> <given-names>V</given-names>
</name>
<name>
<surname>Gautier</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Glasscock</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Simultaneous video-EEG-ECG monitoring to identify neurocardiac dysfunction in mouse models of epilepsy</article-title>. <source>J Vis Exp</source> (<year>2018</year>) (<issue>131</issue>):<elocation-id>57300</elocation-id>. doi: <pub-id pub-id-type="doi">10.3791/57300-v</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stirling</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Forlani</surname> <given-names>G</given-names>
</name>
<name>
<surname>Baker</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Matthews</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Dickenson</surname> <given-names>AH</given-names>
</name>
<etal/>
</person-group>. <article-title>Nociceptor-specific gene deletion using heterozygous NaV1.8-cre recombinase mice</article-title>. <source>Pain</source> (<year>2005</year>) <volume>113</volume>:<fpage>27</fpage>&#x2013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pain.2004.08.015</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shields</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Ahn</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Han</surname> <given-names>C</given-names>
</name>
<name>
<surname>Seal</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>JN</given-names>
</name>
<etal/>
</person-group>. <article-title>Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system</article-title>. <source>Pain</source> (<year>2012</year>) <volume>153</volume>:<page-range>2017&#x2013;30</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.pain.2012.04.022</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vriens</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nilius</surname> <given-names>B</given-names>
</name>
<name>
<surname>Voets</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Peripheral thermosensation in mammals</article-title>. <source>Nat Rev Neurosci</source> (<year>2014</year>) <volume>15</volume>:<page-range>573&#x2013;89</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nrn3784</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patapoutian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Peier</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Story</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Viswanath</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>ThermoTRP channels and beyond: Mechanisms of temperature sensation</article-title>. <source>Nat Rev Neurosci</source> (<year>2003</year>) <volume>4</volume>:<page-range>529&#x2013;39</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nrn1141</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pappas</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Bey</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Rossi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers</article-title>. <source>JCI Insight</source> (<year>2017</year>) <volume>2</volume>:<elocation-id>e92052</elocation-id>. doi: <pub-id pub-id-type="doi">10.1172/jci.insight.92052</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolevzon</surname> <given-names>A</given-names>
</name>
<name>
<surname>Delaby</surname> <given-names>E</given-names>
</name>
<name>
<surname>Berry-Kravis</surname> <given-names>E</given-names>
</name>
<name>
<surname>Buxbaum</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Betancur</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Neuropsychiatric decompensation in adolescents and adults with phelan-McDermid syndrome: a systematic review of the literature</article-title>. <source>Mol Autism</source> (<year>2019</year>) <volume>10</volume>:<fpage>50</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13229-019-0291-3</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Hoorn</surname> <given-names>A</given-names>
</name>
<name>
<surname>Carpenter</surname> <given-names>T</given-names>
</name>
<name>
<surname>Oak</surname> <given-names>K</given-names>
</name>
<name>
<surname>Laugharne</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ring</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shankar</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Neuromodulation of autism spectrum disorders using vagal nerve stimulation</article-title>. <source>J Clin Neurosci</source> (<year>2019</year>) <volume>63</volume>:<fpage>8</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jocn.2019.01.042</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>T</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of stable vagus nerve stimulation efficacy on autistic behaviors in ten pediatric patients with drug resistant epilepsy: An observational study</article-title>. <source>Front Pediatr</source> (<year>2022</year>) <volume>10</volume>:<elocation-id>846301</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fped.2022.846301</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres-Rosas</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yehia</surname> <given-names>G</given-names>
</name>
<name>
<surname>Pena</surname> <given-names>G</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>P</given-names>
</name>
<name>
<surname>del Rocio Thompson-Bonilla</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moreno-Eutimio</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Dopamine mediates vagal modulation of the immune system by electroacupuncture</article-title>. <source>Nat Med</source> (<year>2014</year>) <volume>20</volume>:<page-range>291&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nm.3479</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>A neuroanatomical basis for electroacupuncture to drive the vagal-adrenal axis</article-title>. <source>Nature</source> (<year>2021</year>) <volume>598</volume>:<page-range>641&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41586-021-04001-4</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kupari</surname> <given-names>J</given-names>
</name>
<name>
<surname>Haring</surname> <given-names>M</given-names>
</name>
<name>
<surname>Agirre</surname> <given-names>E</given-names>
</name>
<name>
<surname>Castelo-Branco</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ernfors</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>An atlas of vagal sensory neurons and their molecular specialization</article-title>. <source>Cell Rep</source> (<year>2019</year>) <volume>27</volume>:<fpage>2508</fpage>&#x2013;<lpage>23.e4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.096</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kamm</surname> <given-names>GB</given-names>
</name>
<name>
<surname>Pohle</surname> <given-names>J</given-names>
</name>
<name>
<surname>Reis</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Heppenstall</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The TRPM2 channel is a hypothalamic heat sensor that limits fever and can drive hypothermia</article-title>. <source>Science</source> (<year>2016</year>) <volume>353</volume>:<page-range>1393&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.aaf7537</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haraguchi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kawamoto</surname> <given-names>A</given-names>
</name>
<name>
<surname>Isami</surname> <given-names>K</given-names>
</name>
<name>
<surname>Maeda</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kusano</surname> <given-names>A</given-names>
</name>
<name>
<surname>Asakura</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice</article-title>. <source>J Neurosci</source> (<year>2012</year>) <volume>32</volume>:<page-range>3931&#x2013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4703-11.2012</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Sieracki</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Di</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidant sensing by TRPM2 inhibits neutrophil migration and mitigates inflammation</article-title>. <source>Dev Cell</source> (<year>2016</year>) <volume>38</volume>:<page-range>453&#x2013;62</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.devcel.2016.07.014</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Fleming</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kinnear</surname> <given-names>D</given-names>
</name>
<name>
<surname>Henderson</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pell</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Melville</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Mortality in 787,666 school pupils with and without autism: A cohort study</article-title>. <source>Autism</source> (<year>2021</year>) <volume>25</volume>:<page-range>300&#x2013;4</page-range>. doi: <pub-id pub-id-type="doi">10.1177/1362361320944037</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>